BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3895799)

  • 1. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment.
    Celani MF; Montanini V; Marrama P
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute stimulation with luteinizing hormone-releasing hormone (LRH) on biologically active and immunoreactive serum luteinizing hormone (LH) in pubertal boys.
    Montanini V; Celani MF; Baraghini GF; Carani C; Marrama P
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):289-94. PubMed ID: 6391056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRH-stimulated release of bioactive and immunoreactive LH in a patient with the XX male syndrome.
    Grandi M; Borghi A; Vaccari F; Celani MF
    Exp Clin Endocrinol; 1987 Apr; 89(2):229-32. PubMed ID: 3301372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute stimulation with gonadotropin releasing hormone (GnRH) on biologically active serum luteinizing hormone (LH) in elderly men.
    Celani MF; Montanini V; Baraghini GF; Carani C; Marrama P
    J Endocrinol Invest; 1984 Dec; 7(6):589-95. PubMed ID: 6397502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.
    Burstein S; Schaff-Blass E; Blass J; Rosenfield RL
    J Clin Endocrinol Metab; 1985 Sep; 61(3):508-13. PubMed ID: 3894406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone and follicle-stimulating hormone secretory dynamics in Turner's syndrome.
    Boyar RM; Ramsey J; Chipman J; Fevre M; Madden J; Marks JF
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1078-83. PubMed ID: 122419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in luteinizing hormone biological activity/immunoreactivity ratio in elderly men.
    Marrama P; Montanini V; Celani MF; Carani C; Cioni K; Bazzani M; Cavani D; Baraghini GF
    Maturitas; 1984 Apr; 5(4):223-31. PubMed ID: 6738369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologically active luteinizing hormone (LH) in Klinefelter's syndrome: response to gonadotropin-releasing hormone (GnRH) and effects of testosterone undecanoate.
    Montanini V; Celani MF; Carani C; Cioni K; Simoni M; Baraghini GF; Marrama P
    Andrologia; 1987; 19(1):58-65. PubMed ID: 3318557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogens induce an LH surge in a prepubertal patient with 45,X gonadal dysgenesis under prolonged pulsatile LRH administration.
    Delemarre-van de Waal HA; Van den Brande JL; van Kessel H; Schoemaker J
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):185-9. PubMed ID: 6402864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
    Carani C; Celani MF; Zini D; Baldini A; Della Casa L; Marrama P
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):284-8. PubMed ID: 2648724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the potency of luteinizing hormone by estrogen.
    Lucky AW; Rebar RW; Rosenfield RL; Roche-Bender N; Helke J
    N Engl J Med; 1979 May; 300(18):1034-6. PubMed ID: 431597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
    Jeppsson S; Rannevik G; Thorell JI; Wide L
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects.
    Delemarre-van de Waal HA; Van den Brande JL; Schoemaker J
    J Clin Endocrinol Metab; 1985 Nov; 61(5):859-67. PubMed ID: 3930552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidal regulation of biologically active luteinizing hormone secretion in men and women.
    Veldhuis JD; Dufau ML
    Hum Reprod; 1993 Nov; 8 Suppl 2():84-96. PubMed ID: 8276976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay.
    Dufau ML; Pock R; Neubauer A; Catt KJ
    J Clin Endocrinol Metab; 1976 May; 42(5):958-69. PubMed ID: 1270585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects.
    Dufau ML; Beitins IZ; McArthur JW; Catt KJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):658-67. PubMed ID: 783183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.